Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort

被引:71
作者
Pacheco, Y. M. [1 ]
Jarrin, I. [2 ]
Rosado, I. [1 ]
Campins, A. A. [3 ]
Berenguer, J. [4 ]
Iribarren, J. A. [5 ]
Rivero, M. [6 ]
Munoz-Medina, L. [7 ]
Bernal-Morell, E. [8 ]
Gutierrez, F. [9 ]
Leal, M. [1 ]
机构
[1] Univ Seville, Virgen Rock Univ Hosp, CSIC, Inst Biomed Seville IBiS,Lab Immunovirol,Clin Uni, Seville 41013, Spain
[2] Inst Hlth Carlos III, Madrid, Spain
[3] Hosp Univ Son Espases, Palma de Mallorca, Spain
[4] Gregorio Maranon Gen Univ Hosp, Infect Dis HIV Unit, Madrid, Spain
[5] Hosp Univ Donostia, San Sebastian, Spain
[6] Navarra Hosp, Pamplona, Spain
[7] Hosp Univ San Cecilio, Unidad Enfermedades Infecc, Granada, Spain
[8] Hosp Gen Univ Reina Sofia, Serv Enfermedades Infecc, Madrid, Spain
[9] Univ Miguel Hernandez, Hosp Gen Univ Elche, Dept Clin Med, Infect Dis Unit, Alicante, Spain
关键词
Low-CD4; restoration; Mortality; AIDS; Non-AIDS-defining events; Non-AIDS-defining malignancies; Immunodeficiency; Clinical complications; COMBINATION ANTIRETROVIRAL THERAPY; LONG-TERM MORTALITY; INFECTED PATIENTS; DEFINING MALIGNANCIES; VIRAL SUPPRESSION; CANCER; IMMUNODEFICIENCY; INDIVIDUALS; RECOVERY; PARENTS;
D O I
10.1016/j.antiviral.2015.03.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim was to analyze clinical complications in HIV-infected subjects who persistently maintain low CD4 levels despite virological response to cART in the Spanish CoRIS cohort. The main inclusion criteria were CD4 counts <200 cells/mm(3) at cART-initiation and at least 2 years under cART achieving a viral load <500 copies/mL. Those patients with CD4 counts <250 cells/mm(3) 2 years after cART were classified as the Low-CD4 group, and clinical events were collected from this time-point. Poisson regression models were used to calculate incidence rate ratios of death, AIDS-defining events, serious non-AIDS-defining events (NAE) and of each specific NAE category (non-AIDS-defining malignancies (non-ADM), cardiovascular, kidney- and liver-related events). Of 9667 patients in the cohort, a total of 1128 met the criteria and 287 (25.4%) were classified in the Low-CD4 group. A higher risk of death (aIRR: 4.71; 95% CI: 1.88-11.82; p-value = 0.001) and of non-ADM were observed in this group (aIRR: 2.23; 95% CI: 1.07-4.63; p = 0.03). Our results stress the need to control accelerated aging in this population to counter their increased risk of non-AIDS-defining diseases, particularly cancer, and are consistent with the concept that clinical complications are potentially affected by genetics and lifestyle. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 31 条
  • [11] Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
    Grulich, Andrew E.
    van Leeuwen, Marina T.
    Falster, Michael
    Vajdic, Claire M.
    [J]. LANCET, 2007, 370 (9581) : 59 - 67
  • [12] Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation
    Grulich, Andrew E.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2009, 4 (03) : 183 - 187
  • [13] Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
    Guaraldi, Giovanni
    Orlando, Gabriella
    Zona, Stefano
    Menozzi, Marianna
    Carli, Federica
    Garlassi, Elisa
    Berti, Alessandra
    Rossi, Elisa
    Roverato, Alberto
    Palella, Frank
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 53 (11) : 1120 - 1126
  • [14] Poor CD4 response despite viral suppression is associated with increased non-AIDS-related mortality among HIV patients and their parents
    Helleberg, Marie
    Kronborg, Gitte
    Larsen, Carsten S.
    Pedersen, Gitte
    Pedersen, Court
    Obel, Niels
    Gerstoft, Jan
    [J]. AIDS, 2013, 27 (06) : 1021 - 1026
  • [15] Serious Non-AIDS events: Immunopathogenesis and interventional strategies
    Hsu, Denise C.
    Sereti, Irini
    Ananworanich, Jintanat
    [J]. AIDS RESEARCH AND THERAPY, 2013, 10
  • [16] Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy
    Kesselring, Anouk
    Gras, Luuk
    Smit, Colette
    van Twillert, Gitte
    Verbon, Annelies
    de Wolf, Frank
    Reiss, Peter
    Wit, Ferdinand
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (12) : 1458 - 1465
  • [17] Lapadula G., 2013, HIV EXP EXCH M SEV
  • [18] Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment
    Lapadula, Giuseppe
    Cozzi-Lepri, Alessandro
    Marchetti, Giulia
    Antinori, Andrea
    Chiodera, Alessandro
    Nicastri, Emanuele
    Parruti, Giustino
    Galli, Massimo
    Gori, Andrea
    Monforte, Antonella d'Arminio
    [J]. AIDS, 2013, 27 (05) : 769 - 779
  • [19] A CD4+ Cell Count &lt;200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression
    Loutfy, Mona R.
    Genebat, Miguel
    Moore, David
    Raboud, Janet
    Chan, Keith
    Antoniou, Tony
    Milan, David
    Shen, Anya
    Klein, Marina B.
    Cooper, Curtis
    Machouf, Nima
    Rourke, Sean B.
    Rachlis, Anita
    Tsoukas, Chris
    Montaner, Julio S. G.
    Walmsley, Sharon L.
    Smieja, Marek
    Bayoumi, Ahmed
    Mills, Edward
    Hogg, Robert S.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (04) : 451 - 459
  • [20] Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy
    Masia, Mar
    Padilla, Sergio
    Alvarez, Debora
    Lopez, Juan C.
    Santos, Ignacio
    Soriano, Vicente
    Hernandez-Quero, Jose
    Santos, Jesus
    Tural, Cristina
    del Amo, Julia
    Gutierrez, Felix
    [J]. AIDS, 2013, 27 (02) : 181 - 189